Literature DB >> 7077347

Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values.

M Sandler, C R Ruthven, B L Goodwin, A Lees, G M Stern.   

Abstract

In a group of six Parkinsonian patients and 13 "controls" with non-Parkinsonian neurological disease, there was a high correlation between both free and conjugated phenylacetic acid concentrations in plasma and cerebrospinal fluid taken at about the same time. This compound is the major metabolite of phenylethylamine, the production of which may be disturbed in a number of neuropsychiatric illnesses. Thus plasma measurements might be employed clinically to provide an estimate of central changes in phenylethylamine economy. A small but significantly higher proportion of conjugated phenylacetic acid was present in the plasma (but not cerebrospinal fluid) of Parkinsonians compared with controls.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077347      PMCID: PMC491374          DOI: 10.1136/jnnp.45.4.366

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  The phenethylamine hypothesis of thymic homeostasis.

Authors:  E Fischer
Journal:  Biol Psychiatry       Date:  1975-12       Impact factor: 13.382

2.  Gas chromatographic assay of phenylacetic acid in biological fluids.

Authors:  B L Goodwin; C R Ruthven; M Sandler
Journal:  Clin Chim Acta       Date:  1975-08-04       Impact factor: 3.786

3.  Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites.

Authors:  A N DAVISON; M SANDLER
Journal:  Nature       Date:  1958-01-18       Impact factor: 49.962

4.  Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrier.

Authors:  W A Pedemonte; A D Mosnaim; M Bulat
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-05

5.  Enhanced tyramine conjugation in Parkinson's disease.

Authors:  S M Carter; M B Youdim; M Sandler; K R Hunter; G M Stern
Journal:  Clin Chim Acta       Date:  1974-03-26       Impact factor: 3.786

6.  A phenylethylamine oxidising defect in migraine.

Authors:  M Sandler; M B Youdim; E Hanington
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

7.  Phenylacetate and brain dysfunction in experimental phenylketonuria: synaptic development.

Authors:  Y H Loo; T Fulton; K Miller; H M Wisniewski
Journal:  Life Sci       Date:  1980-10-06       Impact factor: 5.037

8.  Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?

Authors:  M Sandler; C R Ruthven; B L Goodwin; G S King; B R Pettit; G P Reynolds; S P Tyrer; M P Weller; S R Hirsch
Journal:  Commun Psychopharmacol       Date:  1978

9.  Phenylacetate and the enduring behavioral deficit in experimental phenylketonuria.

Authors:  T R Fulton; T Triano; A Rabe; Y H Loo
Journal:  Life Sci       Date:  1980-10-06       Impact factor: 5.037

10.  Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness.

Authors:  M Sandler; C R Ruthven; B L Goodwin; A Coppen
Journal:  Clin Chim Acta       Date:  1979-04-02       Impact factor: 3.786

View more
  6 in total

1.  Phenylacetate induces growth inhibition and apoptosis of human osteosarcoma cells.

Authors:  Jong Hyuk Park; Min Young Park; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Woo Sung Moon; Dong Geun Lee; Myoung Jae Kang
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

2.  Enhanced Retrieval of Taste Associative Memory by Chemogenetic Activation of Locus Coeruleus Norepinephrine Neurons.

Authors:  Ryoji Fukabori; Yoshio Iguchi; Shigeki Kato; Kazumi Takahashi; Satoshi Eifuku; Shingo Tsuji; Akihiro Hazama; Motokazu Uchigashima; Masahiko Watanabe; Hiroshi Mizuma; Yilong Cui; Hirotaka Onoe; Keigo Hikishima; Yasunobu Yasoshima; Makoto Osanai; Ryo Inagaki; Kohji Fukunaga; Takuma Nishijo; Toshihiko Momiyama; Richard Benton; Kazuto Kobayashi
Journal:  J Neurosci       Date:  2020-09-29       Impact factor: 6.167

Review 3.  Potential of antineoplastons in diseases of old age.

Authors:  S R Burzynski
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

4.  Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.

Authors:  H Beckmann; G P Reynolds; M Sandler; P Waldmeier; J Lauber; P Riederer; W F Gattaz
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

5.  Impact of Fermentable Fibres on the Colonic Microbiota Metabolism of Dietary Polyphenols Rutin and Quercetin.

Authors:  Bahareh Mansoorian; Emilie Combet; Areej Alkhaldy; Ada L Garcia; Christine Ann Edwards
Journal:  Int J Environ Res Public Health       Date:  2019-01-21       Impact factor: 3.390

6.  The Bacteriostatic Activity of 2-Phenylethanol Derivatives Correlates with Membrane Binding Affinity.

Authors:  Isabel S Kleinwächter; Stefanie Pannwitt; Alessia Centi; Nadja Hellmann; Eckhard Thines; Tristan Bereau; Dirk Schneider
Journal:  Membranes (Basel)       Date:  2021-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.